Simulation of combinatorial gene knock-outs identifies concurrent targeting of Ras and Bcl-xL as a potential strategy to restore normal behaviour in CP CML while limiting negative effects on normal cells. This evidence concerns the gene BCL2L1 and chronic myelogenous leukemia, BCR-ABL1 positive.